Cargando…
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo
Alternative splicing of the oncogene MDM2 is induced in response to genotoxic stress. MDM2-ALT1, the major splice variant generated, is known to activate the p53 pathway and impede full-length MDM2’s negative regulation of p53. Despite this perceptible tumor-suppressive role, MDM2-ALT1 is also assoc...
Autores principales: | Comiskey, Daniel F., Jacob, Aishwarya G., Sanford, Brianne L., Montes, Matías, Goodwin, Andrew K., Steiner, Haley, Matsa, Eleftheria, Tapia-Santos, Aixa S., Bebee, Thomas W., Grieves, Jessica, La Perle, Krista, Boyaka, Prosper, Chandler, Dawn S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756115/ https://www.ncbi.nlm.nih.gov/pubmed/28892044 http://dx.doi.org/10.1038/onc.2017.282 |
Ejemplares similares
-
Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage
por: Comiskey, Daniel F., et al.
Publicado: (2015) -
Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways
por: Jacob, Aishwarya G., et al.
Publicado: (2014) -
Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma
por: Khurshid, Safiya, et al.
Publicado: (2022) -
Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
por: Ognjanovic, Simona, et al.
Publicado: (2012) -
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013)